Choate Investment Advisors lowered its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 23.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 159,842 shares of the company's stock after selling 48,017 shares during the quarter. Procter & Gamble comprises about 0.4% of Choate Investment Advisors' holdings, making the stock its 29th largest position. Choate Investment Advisors' holdings in Procter & Gamble were worth $22,907,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. grew its holdings in shares of Procter & Gamble by 1,000.0% during the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company's stock worth $25,000 after buying an additional 150 shares during the last quarter. Park Square Financial Group LLC grew its holdings in shares of Procter & Gamble by 65.1% during the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company's stock worth $26,000 after buying an additional 71 shares during the last quarter. Maseco LLP purchased a new position in shares of Procter & Gamble during the fourth quarter worth about $28,000. Saranac Partners Ltd purchased a new position in shares of Procter & Gamble during the third quarter worth about $30,000. Finally, Caitlin John LLC purchased a new position in shares of Procter & Gamble during the third quarter worth about $34,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Transactions at Procter & Gamble
In related news, CEO Ma. Fatima Francisco sold 5,549 shares of the company's stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $165.29, for a total value of $917,194.21. Following the sale, the chief executive officer owned 1,029 shares of the company's stock, valued at approximately $170,083.41. This represents a 84.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.20% of the company's stock.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $144.50 on Monday. The business's 50 day simple moving average is $144.93 and its 200-day simple moving average is $147.95. The firm has a market capitalization of $336.49 billion, a price-to-earnings ratio of 21.13, a price-to-earnings-growth ratio of 6.19 and a beta of 0.41. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $170.99.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The firm had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. During the same quarter in the prior year, the company earned $1.54 EPS. Procter & Gamble's revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Friday, April 24th. This is an increase from Procter & Gamble's previous quarterly dividend of $1.06. Procter & Gamble's dividend payout ratio is currently 63.60%.
Analyst Ratings Changes
A number of equities analysts recently issued reports on the company. Jefferies Financial Group lowered their price target on Procter & Gamble from $179.00 to $175.00 and set a "buy" rating on the stock in a report on Monday, April 20th. Morgan Stanley lowered their price objective on Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating on the stock in a report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $163.00 target price on shares of Procter & Gamble in a research report on Monday, April 27th. Royal Bank Of Canada reduced their price target on Procter & Gamble from $172.00 to $167.00 and set an "outperform" rating for the company in a report on Thursday, April 9th. Finally, BNP Paribas Exane reduced their price target on Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating for the company in a report on Thursday, April 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $161.06.
View Our Latest Stock Report on PG
About Procter & Gamble
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.